bioRxiv Science⌕ Search

Biology subjects

Lieb, A.

Publications and source records attributed to Lieb, A..

7 recordsLinked to original sources

Characterizing Transition State in Mouse Vigilance with EEG-EMG Hypnodensity

Study ObjectivesVigilance-state transitions are continuous biological processes, yet conventional rodent sleep scoring relies on discrete epochs that obscure intermediate states. As no standardized framework exists for characterizing these intermediate states in rodents, this study aimed to characterize the temporal dynamics of transitions in mice and validate a machine-learning approach for objective detection. MethodsChronic EEG and EMG recordings were obtained from male C57BL/6N mice. We extracted 56-second windows containing stable transitions between Wakefulness (WAKE), Non-Rapid Eye Movement Sleep (NREMS), and Rapid Eye Movement Sleep (REMS). Eight trained experts manually annotated the onset and duration of transitions to establish ground truth and assess inter-rater reliability. Using quantitative EEG/EMG features (e.g., spectral power, complexity, EMG variance) derived from stable states, Support Vector Machine (SVM) classifiers were trained to predict transition midpoints in independent test animals. ResultsInter-rater agreement among experts was moderate to low, particularly for WAKE to NREMS and NREMS to REMS transitions, reflecting inherent ambiguity in manual scoring. Temporal analysis revealed distinct dynamics across transition types; NREMS to REMS transitions were significantly longer than all others, while REMS to NREMS transitions were the most abrupt. Despite the variability in human scoring, SVM models trained only on stable-state features successfully predicted expert-defined transition midpoints. ConclusionsOur approach not only characterized the recognizable dynamics across transition types in mice, but also provides a reproducible framework for quantifying sleep-wake transitions, which is crucial for studying arousal stability and related impairments in disease. Statement of SignificanceTraditional sleep scoring enforces discrete boundaries between vigilance states, overlooking transitional dynamics that may be critical for understanding arousal regulation. We developed a novel hypnodensity-based framework to systematically identify and characterize intermediate vigilance states in mice using EEG-EMG recordings. By combining expert annotations with machine learning, we revealed that transitions between sleep and wake involve continuous processes with mixed state features, rather than instantaneous switches. This approach provides the first standardized method for quantifying transitional vigilance states in rodents, enabling deeper investigation of arousal instability in neurological disorders. Our framework advances automated sleep analysis beyond classical three-state classification

neuroscience↗

DISRUPTOR: Computational identification of oncogenic mutants disrupting protein interactions

We report an Osprey-based computational protocol to prospectively identify oncogenic mutations that act via disruption of molecular interactions. It is applicable to analyze both protein-protein and protein-DNA interfaces and has been validated on a dataset of clinically relevant mutations. In addition, it was used to predict previously uncharacterized patient mutations in CDK6 and p16 genes, which were experimentally confirmed to impair complex formation.

cancer biology↗

Characterization of the intrahippocampal kainic acid model in female mice with a special focus on seizure suppression by antiseizure drugs and DMSO

ObjectivesAffecting around 50 million people, men and women likewise, epilepsies are among the most common neurological diseases worldwide. Despite special challenges in the medical treatment of women with epilepsy, previous research has mainly focused on males, in particular preclinical animal studies, leaving a gap that needs to be urgently addressed. The intrahippocampal kainic acid (IHKA) mouse model of temporal lobe epilepsy (TLE) as one of the most frequently studied models in males is used for screening of novel antiepileptic therapies. In this study we investigate the IHKA model of TLE in female mice, in particular drug-resistance of hippocampal paroxysmal discharges. Furthermore, we provide evidence for anti-seizure effects of dimethyl sulfoxide (DMSO) in epileptic, but not naIve mice. MethodsAfter injecting KA unilaterally into the hippocampus of female mice, we monitored the development of epileptiform activity in in-vivo EEG recordings, evaluated responsiveness to the commonly prescribed antiseizure drugs (ASDs) lamotrigine (LTG), oxcarbazepine (OXC) and levetiracetam (LEV) and assessed typical neuropathological alterations of the hippocampus. Moreover, the effect of different doses of DMSO was tested in the IHKA chronic epilepsy model as well as on the PTZ-induced acute seizure threshold in both female and male mice. ResultsIn the IHKA model, female mice replicated the key features of human TLE (EEG and neuropathological changes). Importantly, hippocampal paroxysmal discharges (HPDs) in female mice did not respond to commonly prescribed ASDs, thus representing a suitable model of drug-resistant seizures. The solvent DMSO caused a significant short-term reduction of HPDs, but did not affect the threshold of acute seizures. SignificanceBy characterizing the drug-resistance of HPDs in the IHKA model of TLE in female mice we have laid a foundation for future research addressing sex-specific aspects. Considering the special issues complicating the therapeutic management of women, inclusion of females in the quest for novel treatment strategies is imperative. The observed effect of DMSO on epileptiform activity underlines that its application in epilepsy research is problematic and that the choice of solvent and appropriate vehicle control is crucial.

pharmacology and toxicology↗

Olanzapine: a full and potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics

Designer receptors exclusively activated by designer drugs (DREADDs) derived from muscarinic receptors are a powerful tool to test causality in basic neuroscience, but are also potentially amenable to clinical translation. A major obstacle is however that the widely-used agonist clozapine-N-oxide undergoes conversion to clozapine, which penetrates the blood-brain barrier but has an unfavorable side effect profile. Perlapine has been reported to activate DREADDs at nanomolar concentrations, but is not approved for use in humans by the Food and Drug Administration or European Medicines Agency, limiting its translational potential. Here we report that the atypical antipsychotic drug olanzapine, widely available in various formulations, is a full and potent agonist of the human muscarinic-receptor M4-based DREADD, facilitating clinical translation of chemogenetics to treat CNS diseases.

neuroscience↗

CRISPRa-mediated Kcna1 upregulation decreases neuronal excitability and suppresses seizures in a rodent model of temporal lobe epilepsy

Epilepsy is a major health burden, calling for new mechanistic and therapeutic insights. CRISPR-mediated gene editing shows promise to cure genetic pathologies, although hitherto it has mostly been applied ex-vivo. Its translational potential for treating non-genetic pathologies is still unexplored. Furthermore, neurological diseases represent an important challenge for the application of CRISPR, because of the need in many cases to manipulate gene function of neurons in situ. A variant of CRISPR, CRISPRa, offers the possibility to modulate the expression of endogenous genes by directly targeting their promoters. We asked if this strategy can effectively treat acquired focal epilepsy, focusing on ion channels because their manipulation is known be effective in changing network hyperactivity and hypersynchronisation. We applied a doxycycline-inducible CRISPRa technology to increase the expression of the potassium channel gene Kcna1 (encoding Kv1.1) in mouse hippocampal excitatory neurons. CRISPRa-mediated Kv1.1 upregulation led to a substantial decrease in neuronal excitability. Continuous video-EEG telemetry showed that AAV9-mediated delivery of CRISPRa, upon doxycycline administration, decreased spontaneous generalized tonic-clonic seizures in a model of temporal lobe epilepsy, and rescued cognitive impairment and transcriptomic alterations associated with chronic epilepsy. The focal treatment minimizes concerns about off-target effects in other organs and brain areas. This study provides the proof of principle for a translational CRISPR-based approach to treat neurological diseases characterized by abnormal circuit excitability.

neuroscience↗

Epilepsy gene therapy using non-integrating lentiviral delivery of an engineered potassium channel gene

Refractory focal neocortical epilepsy is a devastating disease for which there is frequently no effective treatment. Gene therapy represents a promising alternative, but treating epilepsy in this way involves irreversible changes to brain tissue, so vector design must be carefully optimized to guarantee safety without compromising efficacy. We set out to develop an epilepsy gene therapy vector optimized for clinical translation. The gene encoding the voltage-gated potassium channel Kv1.1, KCNA1, was codon-optimized for human expression and mutated to accelerate the channels recovery from inactivation. For improved safety, this engineered potassium channel (EKC) gene was packaged into a non-integrating lentiviral vector under the control of a cell type-specific CAMK2A promoter. In a blinded, randomized, placebo-controlled pre-clinical trial, the EKC lentivector robustly reduced seizure frequency in a rat model of focal neocortical epilepsy characterized by discrete spontaneous seizures. This demonstration of efficacy in a clinically relevant setting, combined with the improved safety conferred by cell type-specific expression and integration-deficient delivery, identify EKC gene therapy as ready for clinical translation in the treatment of refractory focal epilepsy.

neuroscience↗

KCC2 overexpression prevents the paradoxical seizure-promoting action of somatic inhibition

Although cortical interneurons are apparently well-placed to suppress seizures, several recent reports have highlighted a paradoxical role of parvalbumin-positive perisomatic-targeting (PV+) interneurons in ictogenesis. Here, we use an acute in vivo model of focal cortical seizures in awake behaving mice, together with closed-loop optogenetic manipulation of PV+ interneurons, to investigate their function during seizures. We show that photo-depolarization of PV+ interneurons rapidly switches from an anti-ictal to a pro-ictal effect within a few seconds of seizure initiation. The pro-ictal effect of delayed photostimulation of PV+ interneurons was not shared with dendrite-targeting somatostatin-positive (SOM+) interneurons. We also show that this switch can be prevented by overexpression of the neuronal potassium-chloride co-transporter KCC2 in principal cortical neurons. These results suggest that strategies aimed at improving the ability of principal neurons to maintain intracellular chloride levels in the face of excessive network activity can prevent interneurons from contributing to seizure perpetuation.

neuroscience↗